Full-Time
Network Administrator
Accelerates antibody drug discovery with data science
Senior
Vancouver, BC, Canada
- You have over 5 years of experience in building and supporting complex networks
- You have experience researching and implementing new technologies and practices
- Ability to continuously learn, work independently, and make decisions with minimal supervision
- Experience in RF (Radio Frequency) planning, Wi-Fi roaming protocols, standards, and .11 protocol
- Experience with 802.1x authentication
- Knowledge and hands-on experience of LAN (wired & wireless), WAN, and Firewall environments; understanding of OSI Layers from physical to application
- Experience with public cloud service providers (e.g. AWS, Microsoft Azure, etc.)
- Experience with VPN technology (GRE, IPSec/SSL VPNs)
- Experience with routing protocols (BGP, OSPF)
- Experience with Terraform, Ansible, or other Automation Platforms
- You show initiative and are proactive about resolving issues
- You thrive in a team-based environment, building solutions that meet the specific needs of a diverse team
- You have excellent documentation and organizational skills with impeccable attention to detail
- You are accountable, reliable, punctual, and resilient, with an unwavering work ethic
- Able to participate in an after hours on-call rotation
- Implementing wired and wireless networking technologies for a fast-growing organization over multiple, global sites
- Collaborating with technical counterparts in other departments to provide network support for their projects
- Providing Tier 2 and Tier 3 support for company infrastructure
- Creating and implementing best practices around network management and security
- Engaging with other departments to understand and document their needs. Providing technical recommendations based on the identified needs
AbCellera stands out as a leader in the biotech industry due to its unique approach to antibody drug discovery, combining expert teams, advanced technology, and data science to expedite the process from target to clinic across various therapeutic areas. The company's competitive edge lies in its ability to enable swift progress, cost reduction, and problem-solving in drug development for both innovative biotechs and leading pharmaceutical companies. Furthermore, AbCellera's commitment to technical innovation is evident in its recent presentation of new data on two T-Cell Engager Programs at SITC 2023, demonstrating its active role in advancing the field.
Company Stage
Series A
Total Funding
$393.1M
Headquarters
Vancouver, Canada
Founded
2012